Resources

We partner with pharma to advance neuroscience research

  • All Resources
  • Press Releases
  • In the news
  • Publications

AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption

NEW ORLEANS, La. (June 11, 2024)—AxoSim, a life science company building human brains in the lab at scale to heal […]

Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks

In 2023, Merck, Sanofi, and Fujifilm Cellular Dynamics collaborated as part of the IMI2 NeuroDerisk initiative to perform a comparative […]

AxoSim Posters Featured at SOT 2024 Annual Meeting  

The Society of Toxicology (SOT) brought together more than 5,000 people for its 63rd Annual Meeting and ToxExpo March 10 […]

Press Release: AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors

AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors —Serial Entrepreneurs Dale Pfost and David Weiner […]

Fierce Biotech: Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary

RESEARCH As Vyant Bio continues its wind-down, the neuroscience research assets of its subsidiary StemoniX have officially been picked up by […]

Latest Acquisition Lands AxoSim in the News

On Tuesday, October 24, 2023,  AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX […]

Press Release: AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY

New Orleans, La. ─ October 24, 2023 ─ AxoSim, Inc., a leader in the development and application of live biomimetic human drug discovery […]

Press Release: AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets

AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets —Combines Three Leading Human Biomimetic Organoid Platform Technologies […]

Nola.Com Op-Ed Featuring AxoSim CEO Lowry Curley, PhD

Check out AxoSim CEO Lowry Curley PhD, and Obatala Sciences CEO Trivia Frazier’s, PhD, MBA, op-ed highlighting their experiences growing companies in Southeast Louisiana and how […]